Profitable failure: antidepressant drugs and the triumph of flawed experiments
Drawing on an analysis of Irving Kirsch and colleagues’ controversial 2008 article in PLoS [Public Library of Science] Medicine on the efficacy of SSRI antidepressant drugs such as Prozac, I examine flaws within the methodologies of randomized controlled trials (RCTs) that have made it difficult f...
Autor principal: | McGoey, L |
---|---|
Formato: | Journal article |
Publicado em: |
SAGE Publications
2010
|
Registos relacionados
-
Methodological mimesis and the value of pharmaceutical failures
Por: McGoey, L
Publicado em: (2009) -
Experimental dissidence: economies of credibility in drug regulation
Por: McGoey, L
Publicado em: (2010) -
Seroxat and the suppression of clinical trial data: regulatory failure and the uses of legal ambiguity
Por: McGoey, L, et al.
Publicado em: (2008) -
The windfalls after the storm
Por: McGoey, L
Publicado em: (2007) -
The Politics of Personalised Medicine: Pharmacogenetics in the Clinic By Adam Hedgecoe
Por: McGoey, L
Publicado em: (2007)